TearLab Corporation operates as an in-vitro diagnostic company in the United States. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. The company’s system enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care. Its TearLab Osmolarity System consists of TearLab disposable, which is a single-use microfluidic microchip; TearLab pen, which is a hand-held device that interfaces with the TearLab disposable; and TearLab reader, which is a small desktop unit that allows for the docking of the TearLab pen, as well as provides a quantitative reading for the operator. The company was formerly known as OccuLogix, Inc. TearLab Corporation was founded in 1996 and is headquartered in San Diego, California.

2 years ago

TearLab

Can sleep position play a role in DED? #dryeye #howdoyousleep
www.eyeworld.org/how-sleep-position-may-affect-dry-eye
... ExpandSee Less

View on Facebook

2 years ago

TearLab

Breaking News: TearLab Submits 510(k) for U.S. FDA Clearance of TearLab Discovery™ Platform www.tearlab.com/investors/press-releases.htm ... ExpandSee Less

View on Facebook

2 years ago

TearLab

Leading authors of TFOS DEWS II provide “universal takeaways” to better understand the report including where to start: bit.ly/2jDeJVl ... ExpandSee Less

View on Facebook

2 years ago

TearLab

EyeWorld’s recent issue focuses on dry eye disease in pre-operative patients. Learn from 5 doctors who share their methods of diagnosing the disease to ensure great outcomes: bit.ly/2Bejts0 ... ExpandSee Less

View on Facebook

2 years ago

TearLab

Problems with the cornea could be caused by undiagnosed #dry eye. Read more about diagnosing #DED to protect patients’ cornea & tear film: bit.ly/2A8Pdyl ... ExpandSee Less

View on Facebook

2 years ago

TearLab

Glaucoma therapy causing ocular surface disease? Learn more about the importance of managing your glaucoma patients’ ocular surface: bit.ly/2Ai4mwc ... ExpandSee Less

View on Facebook

2 years ago

TearLab

Why did you start treating Dry Eye? What tools do you use to diagnose and treat this prevalent disease? Drs. Periman, Mac, and Kontos discuss these questions to help you give symptomatic patients the best care. bit.ly/2hY0KoU ... ExpandSee Less

View on Facebook

TearLab is exhibiting at the ESCRS in Paris. Please come and visit us at booth #F111 #ESCRS19 #osmolarity #dryeye #TearLab

Great video series on Practical Implementation of the ASCRS Cornea Clinical Committee Protocol
#osmolarity #dryeye
https://t.co/s565J0Wief

In this video, Dr. Francis Mah shares his thoughts on the ASCRS OSD Algorithm. #Osmolarity #Dryeye #TearLab
VIDEO: ASCRS cornea committee establishes preop OSD treatment algorithm https://t.co/ADmEcF35ej

Thanks @NAEVRAdvocacy for the #dryeye awareness in your newsletter! Great #teamwork!
#vision #optometry #ophthalmology #eye #health #science #tesearch #TFOSDEWSII @DrBridgitte @MassEyeAndEar @HMSeye @dukeeyecenter @TearLab @NatEyeInstitute @NIH_ORWH

Finalizing details for the upcoming TFOS Ambassador meeting this September…https://t.co/PN99SCja5c #eye #health #dryeye #Europe #optometry #ophthalmology #science #pharma #innovation @JenOculSurf @lwj_63 @j_wolffsohn @sifigroup @TearLab @Thea_Pharma @EntodPharma @BauschLombUK

Load More...

FULL NAME*

What's Your Role?*

WORK EMAIL*

COMPANY NAME*

Company Description*

HOW'D YOU HEAR ABOUT US?

DETAILS ABOUT YOUR GOALS

TearLab Corporation

9980 Huennekens Street
Suite 100
San Diego, CA 92121

+1 (858) 455-6006

www.tearlab.com

September 2019
S M T W T F S
« Aug    
1234567
891011121314
15161718192021
22232425262728
2930  

©2019 ALIGNMT LLC | Alignment Strategy | Mergers & Acquisitions | Investor Relations

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending

Log in with your credentials

or    

Forgot your details?

Create Account